Mar­ket­ingRx roundup: Blue­bird bio pro­motes sick­le cell aware­ness; Pfiz­er, BioN­Tech en­cour­age boost­ers in South

While blue­bird bio is ex­pect­ed to file an ap­pli­ca­tion with the FDA for its sick­le cell dis­ease (SCD) drug can­di­date in the first quar­ter, it’s al­ready rais­ing aware­ness on­line. Two web­sites — one for health­care providers called “Change for SCD” and an­oth­er for pa­tients and care­givers called “Spark Sick­le Cell Change” — fea­ture re­al physi­cians and pa­tients talk­ing about sick­le cell dis­ease stig­ma and oth­er is­sues.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER